These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22398069)

  • 1. A case report: ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis.
    Kinnunen U; Färkkilä M; Mäkisalo H
    J Crohns Colitis; 2012 Jul; 6(6):724-7. PubMed ID: 22398069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report.
    Parra RS; Feitosa MR; Machado VF; Ramalho LN; da Rocha JJ; Feres O
    J Med Case Rep; 2015 Oct; 9():249. PubMed ID: 26518665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.
    Kok B; Lester ELW; Lee WM; Hanje AJ; Stravitz RT; Girgis S; Patel V; Peck JR; Esber C; Karvellas CJ;
    Dig Dis Sci; 2018 Jun; 63(6):1654-1666. PubMed ID: 29564668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo in a patient receiving infliximab for refractory ulcerative colitis.
    Ismail WA; Al-Enzy SA; Alsurayei SA; Ismail AE
    Arab J Gastroenterol; 2011 Jun; 12(2):109-11. PubMed ID: 21684486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.
    Fok KC; Ng WW; Henderson CJ; Connor SJ
    J Crohns Colitis; 2012 Jul; 6(6):708-12. PubMed ID: 22398084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 20-year-old woman with ulcerative colitis and acute liver failure].
    Forker R; Escher M; Stange EF
    Internist (Berl); 2017 Sep; 58(9):982-989. PubMed ID: 28271269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis.
    Wong JC; Bressler B; Salh B; Yoshida EM; Chatur N
    J Crohns Colitis; 2011 Apr; 5(2):162-4. PubMed ID: 21453887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis.
    Veerappan SG; Kennedy M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):588-9. PubMed ID: 18467922
    [No Abstract]   [Full Text] [Related]  

  • 11. In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?
    Caprilli R
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S226-7. PubMed ID: 18816754
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study.
    Ochsenkühn T; Sackmann M; Göke B
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1167-71. PubMed ID: 15489577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis.
    Aratari A; Margagnoni G; Koch M; Papi C
    J Crohns Colitis; 2011 Jun; 5(3):262. PubMed ID: 21575893
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab in ulcerative colitis.
    Aberra FN; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy.
    Rojas-Feria M; Eslam M; Castro-Fernández M; Guerrero P; Larraona-Moreno JL; Romero-Gómez M
    J Crohns Colitis; 2011 Dec; 5(6):608-11. PubMed ID: 22115382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe gram positive bacterial infection in an ulcerative colitis patient treated with Infliximab.
    Marques M; Rodrigues S; Mariz E; Pinto J; Videira T; Brito J; Reis C; Simões-Ventura F; Magro F
    J Crohns Colitis; 2010 Feb; 4(1):110-3. PubMed ID: 21122493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
    Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR
    Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.